Regulatory and strategic complications of oncology drug marketing in Asia
By GlobalData Healthcare 06 May 2021 (Last Updated May 6th, 2021 14:34) The US is the most lucrative market for prescription drugs, routinely generating more than 50% of global sales in multiple therapy areas, including oncology. In the past five years, the Food and Drug Administration (FDA) has approved 88 innovator or new formulation drugs in oncology, few of which have made it into Japan and even fewer into China. Share Article The US is the most lucrative market for prescription drugs, routinely generating more than 50% o...
Source: pharmaceutical-technology.com